NYSE · Medical - Distribution

Cencora, Inc. (COR) Stock

$323.85 +0.78% NYSE: COR Healthcare

Valuation

MetricValue
Price$323.85
Market Cap$63.01B
P/E Ratio22.21
P/B Ratio19.01
P/S Ratio0.18
EPS (TTM)$7.96
52-Week High$377.54
52-Week Low$244.82
Dividend Yield0.80%

Financials & Margins

MetricValue
ROE106.43%
ROA3.13%
ROCE17.62%
Gross Margin1.14%
Operating Margin1.14%
Net Margin0.79%
Debt/Equity3.84
Current Ratio0.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$214.0B$238.6B$262.2B$294.0B$321.3B
Operating Profit$2.7B$2.8B$2.4B$3.0B$3.6B
Net Profit$1.5B$1.7B$1.7B$1.5B$1.6B
EPS$7.39$8.04$8.53$7.53$7.96
Op Margin1.3%1.1%0.9%1.0%1.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$57.3B$56.6B$62.6B$67.1B$76.6B
Total Liabilities$56.8B$56.5B$61.9B$66.3B$74.8B
Cash$2.5B$3.5B$2.7B$3.2B$4.4B
Borrowings$8.8B$7.6B$6.8B$6.7B$10.7B

Latest News

Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers StockStory · Jul 13, 2026 Should You Retain CAH Stock After Removal From Several Russell Indices? Zacks · Jul 9, 2026 McKesson Stock Is Shrinking, and That's The Point for Owners Trefis · Jul 9, 2026 3 Market-Beating Stocks for Long-Term Investors StockStory · Jul 9, 2026 McKesson Stock Is Shrinking, And That's The Point Trefis · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.7B$2.7B$3.9B$3.5B$3.9B
Investing Cash Flow$-6.6B$-865.0M$-3.1B$-1.1B$-5.6B
Financing Cash Flow$-96.0M$-532.0M$-1.3B$-1.6B$-539.0M
Net Cash Flow$-1.5B$523.0M$-841.0M$545.0M$1.1B
Free Cash Flow$2.2B$2.2B$3.5B$3.0B$3.2B

Valuation & Return Ratios

MetricValue
PEG Ratio0.58
EV / EBITDA13.11
FCF Yield6.95%
Quick Ratio0.58
Interest Coverage8.71
Return 1Y4.42%
Return 3Y76.45%
Return 5Y183.55%

Ownership

Insiders Held4.23%
Institutions Held98.98%
Institutions Float Held103.35%
Institutional HolderSharesReport Date
Blackrock Inc.19,943,6372026-03-31
Vanguard Capital Management LLC12,313,4592026-03-31
Vanguard Portfolio Management LLC9,590,4142026-03-31
State Street Corporation9,190,5512026-03-31
Price (T.Rowe) Associates Inc7,323,7062026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHAccendra Health, Inc. $0.43 -3.43% -0.12 $32.78M 0.00%
CAHCardinal Health, Inc. $237.57 -0.58% 31.93 $55.64B 0.89%
HSICHenry Schein, Inc. $83.86 -0.91% 24.53 $9.55B 0.00%
MCKMcKesson Corporation $941.48 +1.21% 24.26 $110.23B 0.41%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd $7.34 +0.00% 10.56 $5.44B 6.95%

About Cencora, Inc.

Cencora, Inc. is led by CEO Robert Mauch, employs 47,000 people, headquartered in Conshohocken, US, publicly traded since 1995.

Cencora, Inc. (COR) stock trades at $323.85 with a market capitalization of $63.01B. The stock is valued at a price-to-earnings (P/E) ratio of 22.21, price-to-book of 19.01, price-to-sales of 0.18. Over the past 52 weeks the stock has ranged between $244.82 and $377.54, and currently trades 14.2% below its 52-week high. It pays a dividend yielding 0.80%.

On profitability, Cencora, Inc. generates a return on equity (ROE) of 106.43% — well above the market average, a sign of a high-quality business, return on capital employed of 17.62%, an operating margin of 1.14%, a net profit margin of 0.79%.

In its most recent fiscal year, Cencora, Inc. reported annual revenue of $321.3B, net profit of $1.6B, revenue has compounded at 11.1% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 3.84 — a leveraged balance sheet worth monitoring, a current ratio of 0.90, total assets of $76.6B, $4.4B in cash and equivalents.

COR has an average daily trading volume of 1,403,509 shares, a beta of 0.57 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides